• Thumbnail for Ataluren
    Ataluren, sold under the brand name Translarna, is a medication for the treatment of Duchenne muscular dystrophy. It was designed by PTC Therapeutics....
    21 KB (1,769 words) - 22:22, 12 July 2024
  • small molecule drugs such as aminoglycosides and negamycin. An oxadiazole, ataluren (previously PTC124), facilitates the selective read-through of aberrant...
    25 KB (2,873 words) - 02:20, 25 September 2024
  • Thumbnail for Duchenne muscular dystrophy
    currently available including gene therapy (Elevidys), and antisense drugs (Ataluren, Eteplirsen etc.). Other medications used include glucocorticoids (Deflazacort...
    65 KB (6,487 words) - 17:31, 7 October 2024
  • Thumbnail for Becker muscular dystrophy
    to dying muscle cells. These patients do not require antisense drugs (Ataluren, Eteplirsen etc.) as certain percentage of dystrophin is already expressed...
    26 KB (2,551 words) - 21:03, 26 August 2024
  • Thumbnail for Muscular dystrophy
    currently available including gene therapy (Elevidys), and antisense drugs (Ataluren, Eteplirsen etc.). Other medications used include glucocorticoids (Deflazacort...
    29 KB (2,231 words) - 00:04, 30 September 2024
  • the FDA in 2015. As of 2015, lumacaftor had no medical use on its own. Ataluren, targeting premature stop codons Kuk K, Taylor-Cousar JL (December 2015)...
    4 KB (171 words) - 13:20, 28 March 2024
  • Thumbnail for RNA
    targeting RNA and approved drugs for human illness. Ribavirin, branaplam, and ataluren are currently available medications that stabilize double-stranded RNA...
    65 KB (7,609 words) - 04:25, 14 October 2024
  • combinations M09AX01 Hyaluronic acid M09AX02 Chondrocytes, autologous M09AX03 Ataluren M09AX04 Drisapersen M09AX05 Aceneuramic acid M09AX06 Eteplirsen M09AX07...
    1 KB (248 words) - 05:17, 18 December 2023
  • Thumbnail for PTC Therapeutics
    (deflazacort) from Marathon Pharmaceuticals. PTC also owns Translarna, (Ataluren) marketed for nonsense mutation Duchenne muscular dystrophy. Together,...
    5 KB (471 words) - 14:05, 18 June 2024
  • with PTC that produced ataluren—Sweeney was the last author on the initial publication of ataluren in Nature in 2007. Ataluren was approved to treat DMD...
    9 KB (876 words) - 06:09, 15 August 2024
  • (Abbott) Atacand atacicept (USAN, INN) ataciguat (INN) atagabalin (USAN, INN) ataluren (USAN, INN) atamestane (INN) ataprost (INN) Atapryl Atarax Atasol atazanavir...
    11 KB (530 words) - 20:38, 27 August 2024
  • constitutive recognition. Ataluren is in clinical trials for the treatment of Duchenne Muscular Dystrophy (DMD). It is believed that Ataluren acts by promoting...
    37 KB (4,392 words) - 04:20, 29 July 2024
  • Thumbnail for Ezutromid
    membrane stained biopsies at baseline and either 24 or 48 weeks. As of 2016, ataluren was the only approved drug in the EU to treat a specific subpopulation...
    11 KB (1,046 words) - 17:55, 24 March 2024
  • Nonsense mutations in the CDKL5 gene could be suppressed by compounds such as ataluren; (PTC Therapeutics), or similar next-generation translation stop readthrough...
    25 KB (2,458 words) - 08:29, 3 July 2024
  • Thumbnail for Rimeporide
    tested in young boys with Duchenne muscular Dystrophy aged 6 to 11 years. Ataluren Biostrophin (experimental) Idebenone (experimental) Spreitzer H (26 May...
    5 KB (379 words) - 23:33, 5 April 2023
  • Thumbnail for James Inglese
    100 times or more. In 2009, his group's mechanistic studies of PTC124 (Ataluren), then in clinical trials for subclasses of cystic fibrosis and muscular...
    12 KB (1,288 words) - 04:49, 2 July 2023
  • BioPharmaceuticals, Inc., with funding provided by the Muscular Dystrophy Association. Ataluren Rimeporide (experimental) Khurdayan VK, Bozzo J, Prous JR (Oct 2005). "Chronicles...
    2 KB (184 words) - 21:53, 19 July 2023